Delivery Order SPE2DB25D9756-SPE2DB25FTKYF
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 25, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 ml vials, a local anesthetic used in surgical and pain management applications. The award was issued without set-aside designation, and performance is scheduled for completion by September 16, 2025,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on August 12, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 mL vials, a local anesthetic medication used in surgical and pain management applications. The delivery order was issued without a set-aside designation and carries an ultimate completion date of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,531.89 by the Defense Logistics Agency on August 27, 2025. The contract calls for the delivery of EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and post-operative pain management. The delivery order is set to be completed by September 18, 2025, with performance taking place at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $37,659.45 for the supply of EXPAREL 266 mg/20 mL vials. The award, made on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $7,531.89 with an ultimate completion date of September 2, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,479.40 by the Defense Logistics Agency (DLA) on August 25, 2025. The delivery order, which carries no set-aside designation, covers the supply of Exparel 266 mg/20 mL vials with an ultimate completion date of September 16, 2025. Exparel is a long-acting local anesthetic used in surgical and pain management applications....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,021.26 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of August 14, 2025. The delivery order is for EXPAREL 266 mg/20 ml vials, a local anesthetic medication used in surgical and pain management applications. This award was issued without a set-aside designation, allowing the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,510.63 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025. The delivery order, which will be completed by August 11, 2025, is for 266 mg/20 mL vials of EXPAREL, a local anesthetic medication commonly used in surgical and pain management applications. This award was issued without a set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of EXPAREL 133 mg/10 mL vials. The contract is valued at $6,092.20 with a firm fixed-price structure and an ultimate completion date of September 23, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted basis....
- SPE2DB25D9756Indefinite Delivery Contract
- SPE2DB25D9756-SPE2DB25FTKYFDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,414.04 by the Defense Logistics Agency (DLA) on September 2, 2025. The contract calls for delivery of EXPAREL 133 mg/10 ml vials, a local anesthetic medication used in surgical and pain management applications. The delivery is scheduled for completion by September 23, 2025, with performance taking place at the vendor's Park Ridge facility. No set-aside designation was applied to this award. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and extending through November 2026. The IDC, established under the SPE2DB program, provides the agency with a streamlined procurement vehicle to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group's positioning as a critical supplier in the federal pharmaceutical supply chain reflects the company's consistent capability to deliver branded and generic prescription drugs, biologics, and specialized medical consumables directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/2/25 |